ABSTRACT
Based on literature research and Delphi expert consensus method, the important acupoints for cancer pain was summarized to provide evidence basis for the formulation of
Subject(s)
Humans , Acupuncture Points , Acupuncture Therapy , Cancer Pain/therapy , Meridians , Neoplasms/therapy , PublicationsABSTRACT
Objective: To study and analyze the waste reutilization in the process of Chinese materia medica (CMM) resources industrialization, in order to provide countermeasures and suggestions for the protection of CMM resources and promote the sustainable development of CMM industry. Methods: Using circular economics to explain the circular pattern and policy mechanism of green development economy that will promote the waste reutilization of CMM. Results: Waste generated from CMM resources industrialization pollutes the ecological environment seriously, forming the bearing pressure of environment, and the key to the development of CMM resources is to solve the problem of the negative externality caused by waste generated in the process of CMM resources industrialization. Conclusion: Promoting the waste reutilization of CMM should establish the green economic network system which is essential to the development of CMM industry and promote green technology innovation with green policy system which is conducive towards green road, and it makes environmental protection combining organically with the efficient use of CMM resources.
ABSTRACT
Twenty-one Chinese literatures and 10 English literatures are included through retrieval of the full text journal database and degree paper database of CNKI and PubMed (1979-2011) in this paper. And the result indicats that regulative effect can be produced on local fascia tissue, corresponding viscera or the form, proliferation of fibroblast and extracellular matrix related factor at acupoints of healthy or pathological rat-oriented animal model through needling, electroacupuncture, moxibustion and pressure. And it has gradually developed into a new tendency of research on acupuncture-moxibustion mechanism.
Subject(s)
Animals , Humans , Mice , Rats , Acupuncture Therapy , Cell Proliferation , Fibroblasts , Cell Biology , Metabolism , MoxibustionABSTRACT
<p><b>OBJECTIVE</b>To evaluate the influence of Shenfu Injection (SHF) on the quality of life of patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy.</p><p><b>METHODS</b>A total of 133 patients with NSCLC receiving at least two cycles of chemotherapy with taxol plus cisplatin (TP)/vinorelbine plus cisplatin (NP) or gemcitabine plus cisplatin (GP) were randomized into SHF pre-treatment group (with SHF given only in the first cycle) and SHF post-treatment group (with SHF given only in the second cycle). The Quality of Life Questionnaire-Core 30 (QLQ-C30) and the Functional Living Index-Cancer (FLIC) were used to evaluate the quality of life of the patients after the treatments.</p><p><b>RESULTS</b>Both of the groups showed improved quality of life after the treatments (P<0.01), but the improvements were more obvious in SHF pre-treatment group (P<0.05). SHF showed favorable effects in relieving such adverse effects as fatigue, nausea, vomiting and diarrhea associated with the chemotherapy.</p><p><b>CONCLUSION</b>SHF can improve the quality of life in NSCLC patients receiving chemotherapies.</p>
Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Antineoplastic Combined Chemotherapy Protocols , Therapeutic Uses , Carcinoma, Non-Small-Cell Lung , Drug Therapy , Cisplatin , Drugs, Chinese Herbal , Therapeutic Uses , Lung Neoplasms , Drug Therapy , Nausea , Paclitaxel , Phytotherapy , Quality of Life , Surveys and Questionnaires , Vinblastine , VomitingABSTRACT
<p><b>OBJECTIVE</b>To observe the effect of Shenfu injection (SFI) in treating non small cell lung cancer (NSCLC) patients on quality of life with gemcitabine (GEM) plus cisplatin (GP) regimen.</p><p><b>METHODS</b>Thirty-four patients were ready to receive GP regimen chemotherapy for treating NSCLC disease, according to lot-drawing, they were divided into SFI pre-treatment group (18 cases) and SFI post-treatment group (16 cases). SFI pre-treatment group: During the first treatment course, chemotherapy was begun with SFI 60 ml, intravenous dripping on the 3rd day, once daily, consecutively for 10 days; on the 1st day, GP regimen (GEM 1250 mg/m(2), intravenous dripping, on the 1st and 8th day; cisplatin 70 mg/m(2) on the 2nd day; 21 days as one cycle) was carried out; in the second treatment course GP regimen was merely given to serve as the self-control. SFI post-treatment group: the medicament sequence order was reversed from that of pre-treatment group. Using dual international quality of life (QOL) scores, the effect of SFI on the patients' QOL was observed through randomized self pre- and post-crossover control.</p><p><b>RESULTS</b>The QOL in the 34 patients after being treated by SFI in combination with GP chemotherapy regimen in one group, and GP chemotherapy regimen alone in the other, was improved in different degrees, with significant difference (P < 0.01); comparison of SFI combined with GP chemotherapy regimen with GP chemotherapy alone showed that QOL in patients was significantly different (P < 0.01).</p><p><b>CONCLUSION</b>SFI could improve QOL in patients with NSCLC who were treated with GP regimen.</p>